Healthcare

eCOA, eSource & Clinical Trials Market Expected to Experience Bolstering Sales during Forecast Period, 2019 to 2029

Kategorie der Pressemeldung: 
Mitteilung: 

The latest Fact.MR study indicates healthcare facilities, contract research organizations, and educational & research institutes collectively spent ~US$ 1,950 Mn on eCOA, eSource and clinical trials solutions in 2018. The eCOA, eSource & clinical trials market is envisaged to witness substantial traction through 2019, with gains primarily driven by the growing penetration of digitization in healthcare sector and substantial increase in pharma spending on clinical trials.

Rapidly expanding deployment of clinical trial solutions, which contributed to ~40% of the total spending on eCOA, eSource, and clinical trials in 2018, will continue to appeal a widening bandwidth of institutions through 2029, says the report.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=4042

Spending on eCOA Set to Quadruple

Dental Anesthetics Sales Upsurge with Major Players Contributing Heavily towards Market Growth, reports Fact.MR study

Kategorie der Pressemeldung: 
Mitteilung: 

Witnessing an average Y-o-Y growth of ~5% in the revenues, the global dental anesthetics market is set to reach the US$ 1 billion market, by 2020. Hospitals will remain the cornerstone of the promising growth outlook of dental anesthetics market, according to a recent study of Fact.MR. The report suggests that half of the overall sales of dental anesthetics is accounted by hospital pharmacies, whereas a third of the total dental anesthetics consumption is registered by hospitals.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=3552

A Meaningful evolution of the dentistry and healthcare industry in recent years has provided a feasible boost to dental anesthetics, thereby driving developments in the market. Dental consumables industry is growing positively in line with the progressing traction and outgrowing dental anesthetics market, over the recent past. The current growth trend of dental anesthetics market has prominently influenced the increasing number of dental patients across all the regions of the globe, says the report.

Innovative Trends Steer Demand for Dental Anesthetics during 2018 to 2028, reports Fact.MR study

Kategorie der Pressemeldung: 
Mitteilung: 

According to a recently published Fact.MR report, the global dental anesthetics market has been prompted due its requirement in oral surgeries, particularly in complicated cases. Furthermore, the inclination towards painless treatment and active prevalence of oral health are other factor motivating the sales of dental anesthetics. In order to gain better insight, readers can access the report titled “Dental Anesthetics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028”, uploaded on the broad online portal managed by Fact.MR.

This intelligent report highlights that sales of dental anesthetics are projected to surpass US$ 880 Mn in 2019; risen from a value of US$ 840 Mn as recorded in 2018. These gains can be accredited to various factors such as upsurge in dental patients, propagation of dentistry centers, and rising awareness about oral health ailments, and others. This study is segregated into different sections underlining primary market factors such as market size (US$ Mn), Y-o-Y growth, market dynamics, supply chain, PEST analysis, pricing analysis, market share comparison and a lot more.

Prefilled Syringes Market Expected to Experience Bolstering Sales during Forecast Period, 2017 - 2026

Kategorie der Pressemeldung: 
Mitteilung: 

Fact.MR has diligently compiled a new research study titled “Prefilled Syringes Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026”, which has been added on its vast online repository. This report spotlights the various trends and opportunities expected to impact the overall development of the global prefilled syringes market. It has been observed that increasing demand for efficient drug delivery systems, specifically for injectable drug delivery, the requirement for innovative injectable drug delivery alternatives has risen. With benefits such as enhanced safety and ease considering standalone drug injecting systems like prefilled syringes, their demand is anticipated to rise at a greater pace in the near future.

According to this intelligent research report, the global market for prefilled syringes is projected to expand at 9.6% CAGR during the period between 2017 and 2026. Furthermore, keeping the sales aspect under serious consideration, more than 10,200,000 thousand units of prefilled syringes are likely to be sold globally by the end of 2026. This assessment functions as a crucial data source for readers, investors and market participants, with an aim to structure their business depending on the prevailing and forecasted market trends.

Hormone Replacement Therapy Market Sales Likely to Surge at Exceptional Rate during Forecast Period, 2018 - 2028

Kategorie der Pressemeldung: 
Mitteilung: 

Based on the recently published Fact.MR report titled “Hormone Replacement Therapy Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028”, sales of hormone replacement therapy products via hospital pharmacies and retail pharmacies are expected to rise with primary developers relying on these channels rather than online selling. This assessment skillfully enlightens the readers about the upcoming developments influencing the hormone replacement therapy market, together with the decisive role of regional marketplaces during the period until 2028.

According to this study, the hormone replacement therapy market is forecasted to expand at a momentous pace. The sales of hormone replacement therapy products are expected to exceed US$ 12,000 Mn by 2019 end. It has been observed that rising incidences of osteoporosis fractures along with growing menopause rates related to women have proven instrumental in steering the demand for hormone replacement therapy. For dropping more light on the target market, Fact.MR predicts that the demand for hormone replacement therapy is likely to surge at a CAGR of 6.0% in terms of value during the stated forecast period, 2018-2028.

Home Diagnostics Market Progress & Manufacturer Contribution Highlighted until 2028

Kategorie der Pressemeldung: 
Mitteilung: 

Fact.MR, in its latest market study, opines that the home diagnostics market will grow at a healthy 3.5% value CAGR, surpassing US$ 6.3 million by 2026. According to the report, sales will remain buoyant in developed regions, with North America and Europe collectively accounting for over 50% revenue share of the market. The Fact.MR study remains bullish on the prospects of home diagnostics market players in developing countries, as growing focus on health & wellness, and emergence of many Asian countries as medical tourism hubs creates opportunities.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

Kidney Stone Management Devices Market Set to Deliver Major Revenue Shares during the Forecast Period

Kategorie der Pressemeldung: 
Mitteilung: 

Global sales of kidney stone management devices are likely to surpass 1 million units by 2028, according to a new Fact.MR study. In terms of revenues, the study projects the kidney stone management devices market to surpass US$ 1,500 million.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=1827

Rising preferences for minimally-invasive and non-invasive surgical procedures continues to be a massive trend in the kidney stone management devices market. Growing incidence rate of kidney stones, combined with the availability of affordable minimally invasive treatment is likely to sustain demand for kidney stone management devices during the forecast period 2018-2028. The report opines that manufacturers will be hard-pressed to develop innovative devices for large stones, as it has remained a longstanding challenge for healthcare providers.

Syringes & Cannulas Market: Infrastructural Advancements Set to Boost Growth during the Forecast Period

Kategorie der Pressemeldung: 
Mitteilung: 

An above-average rise at 4.0% volume CAGR is foreseen for the syringes & cannulas market over the period of forecast, 2018 to 2028, by a new Fact.MR study. Pervasiveness of syringes in terms of the market volume share continues to prevail, whereas the growth rate will also remain higher for these products, compared to cannulas, through 2028. Additionally, majority volume share of worldwide syringes sales is estimated to remain hinged at disposable variants.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2007

North America has traditionally remained the most remunerative market syringes & cannulas, however emergence of Asia-Pacific excluding Japan (APEJ) as a medical tourism hub has paved abundant opportunities for syringes & cannulas manufacturers. The U.S. continues to lead the North American market for syringes & cannulas, whereas majority of APEJ’s syringes and cannulas market continues to remain consolidated in India, trailed by China. The study finds that the U.S., India, and China collectively account for nearly 45% of the overall syringes & cannulas market.

Controlled Substances Market Highlighting Lucrative Avenues Across Major Geographies during 2018-2028

Kategorie der Pressemeldung: 
Mitteilung: 

Worldwide sales of the controlled substances closed in on a valuation of US$ 67,000 Mn in 2018, and are projected to record a Y-o-Y growth at 3.5% in 2019, according to a new Fact.MR study. The study opines that depressants and stimulants have been top-selling class of drugs in the controlled substances market, however gains from marijuana are expected to record over 2X faster growth than all the other controlled substances in 2019 and beyond.

Approval of medical marijuana has been on a significant uptick in various states of the US, trailed by the legalization in Canada for both recreational and medicinal use recently. This has tremendously contributed to the popularity of cannabis stocks, alongside efforts of leading controlled substance manufacturers toward eliminating legal barriers and attracting investor interest. The study estimates marijuana sales in 2019 to record a Y-o-Y growth at 9.3% over 2018.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2032

Histopathology Testing Equipment Market Progress & Manufacturer Contribution Highlighted until 2028

Kategorie der Pressemeldung: 
Mitteilung: 

The rapidly advancing diagnostics space has resulted in development of various companies involved in production of diagnostic equipment as well as distribution of testing apparatus and assemblies. The histopathology testing equipment market is no exception, wherein top five companies involved in the development of histopathology testing equipment account for a significant share of the overall market revenue. Top companies such as Thermo Fisher Scientific, Hoffman-la-Roche Ltd., Leica Biosystems, Agilent Technologies Inc., and Merck KGaA collectively account for a revenue share of over 62% in the histopathology testing equipment market.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2240

Increasing awareness regarding cancer screening coupled with higher demand for advanced histopathology testing equipment from diagnostic centers are expected to provide potential avenues of growth for tier 1 manufacturers. These companies are more focused on new product launches, expansion of their current product lines.

Seiten